PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
0.01
0.01
年范围
0.01
1.35
日变化
-99.03%
每月变动
-99.08%
6个月变化
-99.07%
年变化
-99.07%
前一天收盘价
1.1 4
Open
0.0 1
最低价
0.0 1
High
0.0 1
交易量
5
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 128.95 K
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry 生物技术
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-0.72
市销率
—

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

新闻